These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21219494)

  • 21. Risk contexts and risk behaviors in the Euregion Maas-Rhein: the Boule de Neige intervention for AIDS prevention among drug users.
    Franken IH; Kaplan CD
    AIDS Educ Prev; 1997 Apr; 9(2):161-80. PubMed ID: 9167801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evaluation of a pilot study on needle and syringe exchange program among injecting drug users in a community in Guangdong, China].
    Lin P; Fan ZF; Yang F; Wu ZY; Wang Y; Liu YY; Ming ZQ; Li WJ; Luo W; Fu XB; Mai XR; Xu RH; Feng WY; He Q
    Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Sep; 38(5):305-8. PubMed ID: 15498241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Qualitative evaluation of a peer-based needle syringe programme in Vietnam.
    Ngo AD; Schmich L; Higgs P; Fischer A
    Int J Drug Policy; 2009 Mar; 20(2):179-82. PubMed ID: 18242971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peer counseling perspectives. Harm reduction all around.
    Hemphill ML
    Surviv News (Atlanta Ga); 2005; 16(6):7. PubMed ID: 16388537
    [No Abstract]   [Full Text] [Related]  

  • 25. Emergent properties of HIV risk among injection drug users in Tallinn, Estonia: synthesis of individual and neighbourhood-level factors.
    Uusküla A; McMahon JM; Raag M; Silm S; Rüütel K; Talu A; Abel-Ollo K; Ahas R; Des Jarlais DC
    Sex Transm Infect; 2010 Dec; 86 Suppl 3():iii79-84. PubMed ID: 21098060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Risk factors for hepatitis C among injecting drug users in Oslo].
    Dalgard O; Egeland A; Ervik R; Vilimas K; Skaug K; Steen TW
    Tidsskr Nor Laegeforen; 2009 Jan; 129(2):101-4. PubMed ID: 19151801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Harm reduction policy related to drug use: the needles exchange programs].
    Emmanuelli J
    Med Sci (Paris); 2004 May; 20(5):599-603. PubMed ID: 15190482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis C and its risk management among drug injectors in London: renewing harm reduction in the context of uncertainty.
    Rhodes T; Davis M; Judd A
    Addiction; 2004 May; 99(5):621-33. PubMed ID: 15078237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of syringe deregulation on sources of syringes for injection drug users: preliminary findings.
    Deren S; Cleland CM; Fuller C; Kang SY; Des Jarlais DC; Vlahov D
    AIDS Behav; 2006 Nov; 10(6):717-21. PubMed ID: 16642418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia.
    Vicknasingam B; Narayanan S; Navaratnam V
    Drug Alcohol Rev; 2009 Jul; 28(4):447-54. PubMed ID: 19594801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sex and drugs: the correlations of injecting drug users' risk perception and behavioral patterns.
    Márványkövi F; Melles K; Rácz J
    Subst Use Misuse; 2009; 44(4):569-77. PubMed ID: 19266355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Harm reduction interventions, behaviours and associated health outcomes in France, 1996-2003.
    Emmanuelli J; Desenclos JC
    Addiction; 2005 Nov; 100(11):1690-700. PubMed ID: 16277629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A 21st-century Lazarus: the role of safer injection sites in harm reduction and recovery.
    Strathdee SA; Pollini RA
    Addiction; 2007 Jun; 102(6):848-9. PubMed ID: 17523973
    [No Abstract]   [Full Text] [Related]  

  • 34. Needle exchange programs and drug infection behavior.
    DeSimone J
    J Policy Anal Manage; 2005; 24(3):559-77. PubMed ID: 15973795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of a harm-reduction programme on soft tissue infections among injecting drug users of Kolkata, India.
    Bhattacharya MK; Naik TN; Palit A; Bhattacharya SK
    J Health Popul Nutr; 2006 Mar; 24(1):121-2. PubMed ID: 16796159
    [No Abstract]   [Full Text] [Related]  

  • 36. Incorporating geographic settings into a social network analysis of injection drug use and bloodborne pathogen prevalence.
    Wylie JL; Shah L; Jolly A
    Health Place; 2007 Sep; 13(3):617-28. PubMed ID: 17074527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determinants of injection drug user (IDU) syringe sharing: the relationship between availability of syringes and risk network member characteristics in Winnipeg, Canada.
    Shaw SY; Shah L; Jolly AM; Wylie JL
    Addiction; 2007 Oct; 102(10):1626-35. PubMed ID: 17854339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patterns of drug use and associated harms among rural injecting drug users: comparisons with metropolitan injecting drug users.
    Day C; Conroy E; Lowe J; Page J; Dolan K
    Aust J Rural Health; 2006 Jun; 14(3):120-5. PubMed ID: 16706881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Initiators: an examination of young injecting drug users who initiate others to injecting.
    Bryant J; Treloar C
    AIDS Behav; 2008 Nov; 12(6):885-90. PubMed ID: 18097744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Syringe access for injection drug users in Rhode Island.
    Boutwell A; Rich JD
    Med Health R I; 2004 Jan; 87(1):15-6. PubMed ID: 14989076
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.